Literature DB >> 10235433

APC resistance and other haemostatic variables during pregnancy and puerperium.

U Kjellberg1, N E Andersson, S Rosén, L Tengborn, M Hellgren.   

Abstract

Forty-eight healthy pregnant women were studied prospectively and longitudinally. Blood sampling was performed at 10-15, 23-25, 32-34 and 38-40 weeks of gestation, within one week and at eight weeks postpartum. Classic and modified activated protein C ratio decreased as pregnancy progressed. In the third trimester 92% of the ratios measured with the classic test were above the lower reference level whereas all modified test ratios were normal. Slight activation of blood coagulation was shown with increased levels of prothrombin fragment 1+2, soluble fibrin and D-dimer. Fibrinogen, factor VIII and plasminogen activator inhibitor type I and type 2 increased. Protein S and tissue plasminogen activator activity decreased. Protein C remained unchanged. No correlation was found between the decrease in classic APC ratio and changes in factor VIII, fibrinogen, protein S, prothrombin fragment 1+2 or soluble fibrin, nor between the increase in soluble fibrin and changes in prothrombin fragment 1+2, fibrinogen and D-dimer.

Entities:  

Mesh:

Year:  1999        PMID: 10235433

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

2.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

Review 3.  Pregnancy and Pulmonary Embolism.

Authors:  Christopher Deeb Dado; Andrew Tobias Levinson; Ghada Bourjeily
Journal:  Clin Chest Med       Date:  2018-09       Impact factor: 2.878

4.  Risk of a thrombotic event after the 6-week postpartum period.

Authors:  Hooman Kamel; Babak B Navi; Nandita Sriram; Dominic A Hovsepian; Richard B Devereux; Mitchell S V Elkind
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

Review 5.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

6.  APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.

Authors:  Sara Sedano-Balbás; Mark Lyons; Brendan Cleary; Margaret Murray; Geraldine Gaffney; Majella Maher
Journal:  BMC Pregnancy Childbirth       Date:  2010-03-10       Impact factor: 3.007

7.  The use of a scoring system to guide thromboprophylaxis in a high-risk pregnant population.

Authors:  D Schoenbeck; A Nicolle; K Newbegin; J Hanley; A D Loughney
Journal:  Thrombosis       Date:  2011-09-08

8.  Preanalytical conditions that affect coagulation testing, including hormonal status and therapy.

Authors:  M Blombäck; B A Konkle; M J Manco-Johnson; K Bremme; M Hellgren; R Kaaja
Journal:  J Thromb Haemost       Date:  2007-01-12       Impact factor: 5.824

9.  Portal vein thrombosis after cesarean section in a patient on prolonged bed rest due to threatened preterm labor.

Authors:  Arata Hibi; Kazumasa Mogi
Journal:  Clin Case Rep       Date:  2018-02-06

10.  How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Matej Samos; Tomas Bolek; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.